Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification

Abstract Mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEVs) are known to exert immunosuppressive functions. This study showed that MSC-sEVs specifically convert T helper 17 (Th17) cells into IL-17 low-producer (ex-Th17) cells by degrading RAR-related orphan receptor γt (RORγ...

Full description

Bibliographic Details
Main Authors: Sunyoung Jung, Sunho Lee, Hyun Je Kim, Sueon Kim, Ji Hwan Moon, Hyunwoo Chung, Seong-Jun Kang, Chung-Gyu Park
Format: Article
Language:English
Published: Nature Publishing Group 2023-03-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-023-00949-7
_version_ 1827956977327669248
author Sunyoung Jung
Sunho Lee
Hyun Je Kim
Sueon Kim
Ji Hwan Moon
Hyunwoo Chung
Seong-Jun Kang
Chung-Gyu Park
author_facet Sunyoung Jung
Sunho Lee
Hyun Je Kim
Sueon Kim
Ji Hwan Moon
Hyunwoo Chung
Seong-Jun Kang
Chung-Gyu Park
author_sort Sunyoung Jung
collection DOAJ
description Abstract Mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEVs) are known to exert immunosuppressive functions. This study showed that MSC-sEVs specifically convert T helper 17 (Th17) cells into IL-17 low-producer (ex-Th17) cells by degrading RAR-related orphan receptor γt (RORγt) at the protein level. In experimental autoimmune encephalomyelitis (EAE)-induced mice, treatment with MSC-sEVs was found to not only ameliorate clinical symptoms but also to reduce the number of Th17 cells in draining lymph nodes and the central nervous system. MSC-sEVs were found to destabilize RORγt by K63 deubiquitination and deacetylation, which was attributed to the EP300-interacting inhibitor of differentiation 3 (Eid3) contained in the MSC-sEVs. Small extracellular vesicles isolated from the Eid3 knockdown MSCs by Eid3-shRNA failed to downregulate RORγt. Moreover, forced expression of Eid3 by gene transfection was found to significantly decrease the protein level of RORγt in Th17 cells. Altogether, this study reveals the novel immunosuppressive mechanisms of MSC-sEVs, which suggests the feasibility of MSC-sEVs as an attractive therapeutic tool for curing Th17-mediated inflammatory diseases.
first_indexed 2024-04-09T15:11:53Z
format Article
id doaj.art-787e543b53354489b9d8a28a17b5418b
institution Directory Open Access Journal
issn 2092-6413
language English
last_indexed 2024-04-09T15:11:53Z
publishDate 2023-03-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj.art-787e543b53354489b9d8a28a17b5418b2023-04-30T11:08:34ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132023-03-0155366567910.1038/s12276-023-00949-7Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modificationSunyoung Jung0Sunho Lee1Hyun Je Kim2Sueon Kim3Ji Hwan Moon4Hyunwoo Chung5Seong-Jun Kang6Chung-Gyu Park7Department of Microbiology and Immunology, Seoul National University College of MedicineDepartment of Microbiology and Immunology, Seoul National University College of MedicineDepartment of Biomedical Sciences, Seoul National University College of MedicineDepartment of Microbiology and Immunology, Seoul National University College of MedicineSamsung Genome Institute, Samsung Medical CenterDepartment of Microbiology and Immunology, Seoul National University College of MedicineDepartment of Microbiology and Immunology, Seoul National University College of MedicineDepartment of Microbiology and Immunology, Seoul National University College of MedicineAbstract Mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEVs) are known to exert immunosuppressive functions. This study showed that MSC-sEVs specifically convert T helper 17 (Th17) cells into IL-17 low-producer (ex-Th17) cells by degrading RAR-related orphan receptor γt (RORγt) at the protein level. In experimental autoimmune encephalomyelitis (EAE)-induced mice, treatment with MSC-sEVs was found to not only ameliorate clinical symptoms but also to reduce the number of Th17 cells in draining lymph nodes and the central nervous system. MSC-sEVs were found to destabilize RORγt by K63 deubiquitination and deacetylation, which was attributed to the EP300-interacting inhibitor of differentiation 3 (Eid3) contained in the MSC-sEVs. Small extracellular vesicles isolated from the Eid3 knockdown MSCs by Eid3-shRNA failed to downregulate RORγt. Moreover, forced expression of Eid3 by gene transfection was found to significantly decrease the protein level of RORγt in Th17 cells. Altogether, this study reveals the novel immunosuppressive mechanisms of MSC-sEVs, which suggests the feasibility of MSC-sEVs as an attractive therapeutic tool for curing Th17-mediated inflammatory diseases.https://doi.org/10.1038/s12276-023-00949-7
spellingShingle Sunyoung Jung
Sunho Lee
Hyun Je Kim
Sueon Kim
Ji Hwan Moon
Hyunwoo Chung
Seong-Jun Kang
Chung-Gyu Park
Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
Experimental and Molecular Medicine
title Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
title_full Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
title_fullStr Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
title_full_unstemmed Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
title_short Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification
title_sort mesenchymal stem cell derived extracellular vesicles subvert th17 cells by destabilizing rorγt through posttranslational modification
url https://doi.org/10.1038/s12276-023-00949-7
work_keys_str_mv AT sunyoungjung mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT sunholee mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT hyunjekim mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT sueonkim mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT jihwanmoon mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT hyunwoochung mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT seongjunkang mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification
AT chunggyupark mesenchymalstemcellderivedextracellularvesiclessubvertth17cellsbydestabilizingrorgtthroughposttranslationalmodification